IL-1RII Antibodies

Santa Cruz Biotechnology provides a broad selection of IL-1RII monoclonal antibodies for various research applications. IL-1RII monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Interleukin-1 receptor type II (IL-1RII) plays a crucial role in modulating the immune response by acting as a decoy receptor for interleukin-1 (IL-1), thereby inhibiting its pro-inflammatory effects. This regulation is vital for maintaining homeostasis and preventing excessive inflammation, which can lead to various diseases. Understanding the function of IL-1RII is essential for developing therapeutic strategies targeting inflammatory conditions. IL-1RII research has significant implications in understanding autoimmune disorders and inflammatory diseases. Investigating IL-1RII signaling pathways provides valuable insights into immune system regulation and potential therapeutic interventions. Current research focuses on understanding how IL-1RII influences various inflammatory conditions and immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of IL-1RII's role in immune system regulation and disease treatment.